The Patent Finder

Phanes Therapeutics, Inc.

Also on record
Records under this name other than the patents Phanes Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Showing 1 to 3 of 3 · Back to Phanes Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,390,679Anti-Lag 3 Antibodies and Uses Thereof
Lapsed on the fee record
Ended Jul 19, 2026 · High confidence
Lapsed on the fee recordEnded Jul 19, 2026High confidence
US 11,365,242Anti-apelin antibodies and uses thereof
Lapsed on the fee record
Ended Jun 21, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 21, 2026USPTO record
US 11,306,151Anti-TIP-1 antibodies and uses thereof
Lapsed on the fee record
Ended Apr 19, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 19, 2026USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited